TrimRX
US$ 26.06
glp 1 agonist for prediabetes GLP-1 Agonists - What is it? Glucometabolic outcomes of GLP-1 receptor
Description
According to FDA labeling and clinical trials, HbA1c reductions of 1.01.5% are common in patients with type 2 diabetes, though the exact reduction varies by baseline A1c, dose, and individual response
Current GLP-1 medications on the market are administered as once-weekly injections
The gut knows you are eating and tells the pancreas to get ready to pack away the extra calories as fat
They generally improve cardiovascular outcomes and have a low risk of causing hypoglycemia compared to other diabetes medications
doi: 10.1097/MCC.0000000000001294 40
